Senseonics Holdings, Inc., a medical technology company, focuses on the design, development, and commercialization of glucose monitoring systems for people with diabetes. Its first generation continuous glucose monitoring system, Eversense measures glucose levels in people with diabetes for a period of up to 90 days. The company was founded in 1996 and is headquartered in Germantown, Maryland.